NOV 05, 2018 10:00 AM PST

Drug Combination Halts The Progression of Fibrosis

WRITTEN BY: Nouran Amin

After seven years of research, scientists at Anglia Ruskin University, University College London and KU Leuven—developed a drug combination that holds a great deal of potential to halt the progression of Fibrosis.

Credit: Nordic Life Science

 

Initially, the researchers created a model that tests 21 different drugs to treat a disease in men called Peyronie's Disease. When tested on cells and animal models, they found that combining phosphodiesterase type 5 inhibitors (PDE5i) such as vardenafil (Levitra), sildenafil (Viagra) or tadalafil (Cialis) with selective estrogen receptor modulators (SERM) such as tamoxifen or raloxifene—treated fibrosis that causes Peyronie's Disease. Essentially, halting the progression.

 

"The principle of fibrosis is what causes Peyronie's Disease and so this is an important breakthrough. Although we do not believe this particular drug combination will be able to reverse the fibrotic process, it has the potential to treat all fibrotic diseases and halt progression,” says lead author Professor Selim Cellek, of Anglia Ruskin University. "This is an extremely exciting development and one that has taken several years of hard work. Fibrosis is a very serious condition that, when it affects a major organ, can be fatal.”

 

According to the study published in the journal European Urology, Fibrosis is known to cause half of all deaths. Responsible for conditions like cirrhosis of the liver, kidney, lung and heart—fibrosis occurs when damage causes a type of cell, called fibroblast, to convert itself into another type of cell called myofibroblast for the purpose of wound healing.

Image Credit: Promedior

After healing, the tissue that was previously damaged will return to its normal structure. However, in some cases that is not the case because the cells responsible, the myofibroblasts, will go out of control and 'overheal' the wound—causing scar tissue that holds no biological function.

 

Since scar tissue is dead tissue, its presence on major organs like the kidney, lungs, liver or heart, it is a serious tissue and estimated by the United States government cause 45% of all deaths. Developing a drug that can treat such an issue could save many lives. "To our knowledge, this is the first study of its kind to show a synergy between these two types of drugs. We look forward to taking this novel combination to clinical trials in the near future,” states Cellek.

Source: European Urology, Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Medications Used for Atrial fibrillation May Increase Falls
Falls among older adults are a growing health concern that often lead to injury, hospitalization, and other severe complications. Older adults are even at...
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Can Psychedelics Treat Alcoholism?
Some of the first research on psychedelics in clinical settings was to assess their efficacy in treating alcoholism. In fact, LSD-based treatments for the ...
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
A Diabetic Drug that Promotes Brain Repair...But it Only Works in Females
Gender discrimination in research has long stopped serious advancements. In neuroscience, scientists believed that male brains are straightforward and do n...
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Injectable Hydrogel Found Safe for Heart Repair
The first successful in-human clinical trial of an injectable hydrogel that aims to repair heart damage and restore cardiac function was recently conducted...
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Therapeutic To Treat The Detrimental Effects of Marijuana
As U.S. states continue to legalize the use of marijuana, so is the number of American women using cannabis before becoming pregnant and to treat morning s...
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Metformin Offers No Muscle Mass Gain for Older Adults
A clinical trial initiated by Researchers at the University of Kentucky began a clinical study to address the long-held hypothesis that metformin, the diab...
Loading Comments...